Line Bjørge

9.1k total citations
138 papers, 2.9k citations indexed

About

Line Bjørge is a scholar working on Obstetrics and Gynecology, Immunology and Reproductive Medicine. According to data from OpenAlex, Line Bjørge has authored 138 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Obstetrics and Gynecology, 40 papers in Immunology and 40 papers in Reproductive Medicine. Recurrent topics in Line Bjørge's work include Ovarian cancer diagnosis and treatment (37 papers), Pregnancy and preeclampsia studies (23 papers) and Endometrial and Cervical Cancer Treatments (23 papers). Line Bjørge is often cited by papers focused on Ovarian cancer diagnosis and treatment (37 papers), Pregnancy and preeclampsia studies (23 papers) and Endometrial and Cervical Cancer Treatments (23 papers). Line Bjørge collaborates with scholars based in Norway, United States and Sweden. Line Bjørge's co-authors include Roald Matre, Seppo Meri, Jone Trovik, Juha Hakulinen, Ingfrid S. Haldorsen, Tone Skeie Jensen, Ole Erik Iversen, Rigmor Austgulen, Liv Cecilie Vestrheim Thomsen and Øyvind Salvesen and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Line Bjørge

124 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Line Bjørge Norway 32 1.0k 764 683 633 583 138 2.9k
K. Czerwenka Austria 41 1.0k 1.0× 827 1.1× 781 1.1× 1.5k 2.3× 1.3k 2.2× 179 4.6k
Ivo Meinhold‐Heerlein Germany 27 589 0.6× 384 0.5× 956 1.4× 800 1.3× 528 0.9× 133 2.5k
Nicolaì Maass Germany 33 652 0.6× 416 0.5× 553 0.8× 1.3k 2.1× 1.8k 3.1× 274 4.9k
Hidetaka Katabuchi Japan 41 1.5k 1.5× 1.0k 1.3× 2.0k 3.0× 1.4k 2.3× 1.1k 1.8× 191 5.1k
Gilad Ben‐Baruch Israel 39 1.3k 1.2× 333 0.4× 1.7k 2.5× 1.4k 2.2× 995 1.7× 152 4.7k
Eric L. Jenison United States 18 563 0.5× 417 0.5× 1.5k 2.2× 574 0.9× 578 1.0× 37 2.6k
Ami Fishman Israel 27 729 0.7× 129 0.2× 1.1k 1.6× 529 0.8× 485 0.8× 121 2.5k
Isamu Ishiwata Japan 24 387 0.4× 300 0.4× 234 0.3× 689 1.1× 346 0.6× 144 2.0k
Alistair Williams United Kingdom 39 1.6k 1.5× 1.1k 1.4× 2.1k 3.1× 719 1.1× 544 0.9× 101 4.3k
Marlena S. Fejzo United States 33 572 0.5× 287 0.4× 276 0.4× 971 1.5× 544 0.9× 68 3.0k

Countries citing papers authored by Line Bjørge

Since Specialization
Citations

This map shows the geographic impact of Line Bjørge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Line Bjørge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Line Bjørge more than expected).

Fields of papers citing papers by Line Bjørge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Line Bjørge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Line Bjørge. The network helps show where Line Bjørge may publish in the future.

Co-authorship network of co-authors of Line Bjørge

This figure shows the co-authorship network connecting the top 25 collaborators of Line Bjørge. A scholar is included among the top collaborators of Line Bjørge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Line Bjørge. Line Bjørge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Herzog, Chiara, Allison Jones, Iona Evans, et al.. (2025). Systems epigenetic approach towards non-invasive breast cancer detection. Nature Communications. 16(1). 3082–3082. 3 indexed citations
3.
Vistad, Ingvild, Sveinung Berntsen, Ingrid Demmelmaier, et al.. (2025). Empowerment and quality of life in gynecological cancer survivors: Outcomes from a multicenter quasi‐experimental cohort study from Norway (the LETSGO trial). Cancer. 131(16). e70040–e70040.
4.
5.
6.
7.
Thomsen, Liv Cecilie Vestrheim, et al.. (2024). Altered exosomal miRNA profiles in patients with paraneoplastic cerebellar degeneration. Annals of Clinical and Translational Neurology. 11(12). 3255–3266. 3 indexed citations
8.
Dongre, Harsh, Liv Cecilie Vestrheim Thomsen, Anne Christine Johannessen, et al.. (2023). TP53 mutation and human papilloma virus status as independent prognostic factors in a Norwegian cohort of vulva squamous cell carcinoma. Acta Obstetricia Et Gynecologica Scandinavica. 103(1). 165–175. 7 indexed citations
9.
Bentzen, Anne Gry, Elisabeth Berge Nilsen, Ingvild Vistad, et al.. (2023). Real-world data on niraparib maintenance treatment in patients with non-gBRCA mutated platinum-sensitive recurrent ovarian cancer. International Journal of Gynecological Cancer. 33(12). 1898–1905. 4 indexed citations
10.
Helland, Åslaug, Geir Olav Hjortland, Line Bjørge, et al.. (2023). 1235P Enrichment of rare cancers in pragmatic precision cancer medicine trial: Experience from IMPRESS-Norway. Annals of Oncology. 34. S721–S722.
11.
Helland, Åslaug, Sigbjørn Smeland, Hege G. Russnes, et al.. (2023). IMPRESS-Norway: Improving public cancer care by implementing precision cancer medicine in Norway.. Journal of Clinical Oncology. 41(16_suppl). e15188–e15188.
12.
13.
Austdal, Marie, Ann‐Charlotte Iversen, Tone F. Bathen, et al.. (2023). Primary Treatment Effects for High-Grade Serous Ovarian Carcinoma Evaluated by Changes in Serum Metabolites and Lipoproteins. Metabolites. 13(3). 417–417. 2 indexed citations
14.
Barrett, James E., Allison Jones, Iona Evans, et al.. (2022). The DNA methylome of cervical cells can predict the presence of ovarian cancer. Nature Communications. 13(1). 448–448. 32 indexed citations
15.
Berg, Hege F., Heidi Espedal, Aashish Srivastava, et al.. (2021). Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis. Communications Medicine. 1(1). 20–20. 36 indexed citations
16.
Thomsen, Liv Cecilie Vestrheim, Tamim Abdelaal, Jørn Skavland, et al.. (2021). Phenotypic Characterization by Mass Cytometry of the Microenvironment in Ovarian Cancer and Impact of Tumor Dissociation Methods. Cancers. 13(4). 755–755. 6 indexed citations
17.
Austdal, Marie, Liv Cecilie Vestrheim Thomsen, Line Haugstad Tangerås, et al.. (2015). Metabolic profiles of placenta in preeclampsia using HR-MAS MRS metabolomics. Placenta. 36(12). 1455–1462. 52 indexed citations
18.
Macsali, Ferenc, Cecilie Svanes, Robert B. Sothern, et al.. (2012). Menstrual Cycle and Respiratory Symptoms in a General Nordic–Baltic Population. American Journal of Respiratory and Critical Care Medicine. 187(4). 366–373. 28 indexed citations
19.
Baste, Valborg, et al.. (2012). Pregnancy Outcomes After Paternal Radiofrequency Field Exposure Aboard Fast Patrol Boats. Journal of Occupational and Environmental Medicine. 54(4). 431–438. 13 indexed citations
20.
Haram, Kjell, et al.. (2000). Patofysiologi og kliniske manifestasjoner ved preeklampsi. Tidsskrift for Den Norske Laegeforening.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Czerwenka Breakdown of academic impact, for papers by Ivo Meinhold‐Heerlein Breakdown of academic impact, for papers by Nicolaì Maass Breakdown of academic impact, for papers by Hidetaka Katabuchi Breakdown of academic impact, for papers by Gilad Ben‐Baruch Breakdown of academic impact, for papers by Eric L. Jenison Breakdown of academic impact, for papers by Ami Fishman Breakdown of academic impact, for papers by Isamu Ishiwata Breakdown of academic impact, for papers by Alistair Williams Breakdown of academic impact, for papers by Marlena S. Fejzo
Rankless by CCL
2026